Exiqon has launched two new ProbeLibrary expression analysis kits,
covering the genomes of Arabidopsis thaliana and
Drosophila melanogaster, the most widely used models in
disease process and drug target studies.
RNA interference (RNAi) therapeutics to combat human illnesses such
as Huntingdon's disease, amyotrophic lateral sclerosis and
hepatitis C are set to fuel the rapid growth in the RNAi research
product market over the next year.
Researchers at the University of Rochester Medical Center, using GE
Healthcare's CodeLink microarrays, have identified key changes in
gene expression that provide an improved understanding of the
malfunction and death of the...
Key changes discovered in gene expression that provide an improved
understanding of neurones controlling movement and coordination and
their malfunction and death in Parkinson's Disease has lead to the
possibility of a drug therapy...
A team of researchers has issued a plea that that
microarray-derived gene expression data should be available in a
public repository in the same way that gene sequence data is
collated for use by all.
A US biophysicist has won an award for developing a new process
that simplifies the production of proteins in the widely used T7
gene expression system.
Dowpharma has unveiled plans to consolidate its biopharmaceutical
custom process development activities to a single site in the US
that it says will make it easier to respond to its clients' needs.
Switzerland's Lonza has negotiated exclusive rights to an
expression system, used in the manufacture of therapeutic proteins,
that could be used to shorten the development time for its
customers' biologic products.
A combination of a microarray technology developed by Switzerland's
Zeptosens and signal processing software from US firm ViaLogy has
provided a quantum leap in the sensitivity of gene expression
testing in a new study.
Researchers in the US have published the first raft of data from
the GENSAT project, designed to track the maze of connections
between cells in the CNS.
German instrument, consumable and reagent company Eppendorf has
introduced a new range of low-density DNA microarrays for
differential gene expression analyses.
Pharmagene has reported a near-doubling in turnover in the first
half of this year, on the back of strong growth in its drug
discovery services division.
The market for non-array products used in the analysis of the
transcriptome - a map of gene expression and mRNA in the cell - is
maturing quickly but will still grow at more than 14 per cent a
year between 2003 and 2008, says a report...
A new approach to identifying patterns in gene expression analysis
has been shown to be more effective than the most popular method in
a joint Penn State and University at Buffalo study, write US
scientists this week.
Genicon Sciences this week launched its second Resonance Light
Scattering (RLS) technology product - an RLS-based two-colour
nucleic Acid microarray toolkit for gene expression analysis.